HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension.

Abstract
The objective of this study was to determine whether a combination of inhaled nitric oxide (iNO) and O(2) is more effective than 100% O(2) or iNO alone for acute vasodilator testing in children. An open, prospective, randomized, controlled trial was conducted at 16 centers. Subjects were children 4 weeks to 18 years of age with pulmonary hypertension (PH) and increased pulmonary vascular resistance (PVR) undergoing right heart catheterization for acute vasodilator testing. All patients were tested with each of three agents (80 ppm iNO, 100% O(2), combination of 80 ppm iNO/100% O(2)) in three 10-min treatment periods, and hemodynamic measurements obtained. Primary outcome measures were percentages of acute responders with O(2) alone vs. iNO/O(2) and iNO alone vs. iNO/O(2). More patients on the combination were acute responders compared with O(2) or iNO alone (26% vs. 14%, P = 0.019, and 27% vs. 24%, P = 0.602, respectively). Changes in PVR index and mean pulmonary arterial pressure vs. baseline were greater with iNO/O(2) vs. either O(2) or iNO alone (P < 0.001). Survival at 1-year follow-up included (1) 90.9% of acute responders to the combination, compared with 77.8% of nonresponders to the combination, and (2) 85.7% of acute responders to O(2) alone, compared with 80.6% of nonresponders to O(2). Key conclusions are as follows. In children with PH and increased PVR, more acute responders were identified with the iNO/O(2) combination vs. O(2) alone. While there was no significant difference in acute responder rate with iNO alone vs. iNO/O(2), the combination improved pulmonary hemodynamics acutely better than iNO alone. One-year survival data show similar rates between the iNO/O(2) and the O(2) alone groups; however, the combination may be more effective than O(2) alone in discriminating survivors versus nonsurvivors at long-term follow-up.
AuthorsRobyn J Barst, Gabriella Agnoletti, Alain Fraisse, James Baldassarre, David L Wessel, NO Diagnostic Study Group
JournalPediatric cardiology (Pediatr Cardiol) Vol. 31 Issue 5 Pg. 598-606 (Jul 2010) ISSN: 1432-1971 [Electronic] United States
PMID20405117 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Nitric Oxide
  • Oxygen
Topics
  • Administration, Inhalation
  • Adolescent
  • Analysis of Variance
  • Cardiac Catheterization
  • Child
  • Child, Preschool
  • Cross-Over Studies
  • Female
  • Hemodynamics
  • Humans
  • Hypertension, Pulmonary (diagnosis, drug therapy, physiopathology)
  • Infant
  • Infant, Newborn
  • Male
  • Nitric Oxide (administration & dosage, therapeutic use)
  • Oxygen (administration & dosage, therapeutic use)
  • Prospective Studies
  • Survival Rate
  • Vascular Resistance
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: